Loading insider details...
Beta
Latest Form 4 (Jul 22, 2026): Grant/Award of 10,826 QTTB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 22, 2026 | Q32 Bio Inc. (QTTB) | Grant/Award | 10,826 | n/a |
| Jun 5, 2026 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 17,786 | n/a |
| Mar 12, 2026 | Stoke Therapeutics, Inc. (STOK) | Exercise/Conversion | 3,955 | $32.9K |
| Oct 28, 2025 | Q32 Bio Inc. (QTTB) | Grant/Award | 53,521 | n/a |
| Mar 20, 2025 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 122,651 | n/a |
| Feb 27, 2025 | Q32 Bio Inc. (QTTB) | Disposition to Issuer | 25,674 | n/a |
| Aug 14, 2024 | Q32 Bio Inc. (QTTB) | Exercise/Conversion | 1,095 | n/a |
| Jun 7, 2024 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 7,639 | n/a |
| Mar 27, 2024 | Q32 Bio Inc. (QTTB) | Grant/Award | 12,767 | n/a |
| Feb 15, 2024 | Homology Medicines, Inc. (FIXX) | Exercise/Conversion | 14,280 | n/a |